December 8, 2014
Levine Media Group's The Bio Report podcast named a runner-up by Forbes' David Shaywitz as this year's "Most essential podcast for aspiring healthcare innovators."
October 28, 2014
Serenus Names Accomplished Group of Researchers to Scientific Advisory Board
SAN FRANCISCO AND JOHANNESBERG—OCTOBER 28, 2014—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, today announced appointment of a group of accomplished researchers to its newly established Scientific Advisory Board.
October 14, 2014
Jump Capital Names Garrett Vygantas to Head New San Francisco Office, Lead Healthcare Practice
CHICAGO—OCTOBER 14, 2014—Jump Capital, a leading Chicago-based venture capital firm, today announced that Garrett Vygantas, M.D. will head the firm’s newly-established San Francisco office and lead its healthcare practice.
August 21, 2014
Levine Media Group Launches The Bio Report Podcast
Veteran journalist Daniel Levine hosts weekly episodes focused on biotechnology at the intersection of business, science, and policy.
BERKELEY, CALIFORNIA—AUGUST 21, 2014—The Levine Media Group today launched The Bio Report, a weekly podcast hosted by veteran journalist Daniel Levine. Levine, principal of the Levine Media Group, had hosted The Burrill Report podcast since 2008.
July 23, 2014
Webinar Replay: Using Successful Online Fundraising Strategies
Online fundraising has made it easier to raise money to support your cause at anytime, anywhere. But if the possibilities are endless, why do so many of us feel disappointed when all of our efforts amount to very little?
This webinar will address why this often happens and the steps you can take to ensure your fundraising efforts run more smoothly and successfully. This includes understanding the necessary prep work, the importance of relationship building, social media implementation, and other considerations. Panelists share strategies they have adopted, challenges they have overcome, and success stories. Levine Media Group's Daniel Levine moderates.
July 23, 2014
Using Successful Online Fundraising Strategies
Levine Media Group's Daniel Levine will be moderating a Global Genes webinar on successful online fundraising July 30, 2014 at noon PT. There's a great group of panelist with a track record of success. To learn more or register for free, please click the link above.
June 25, 2014
Accelerating Growth: Forging India’s Bioeconomy released at 2014 BIO International Convention
In 2012, the Association of Biotechnology Led Enterprises (ABLE) laid out a goal of growing India’s bioeconomy to more than $100 billion by 2025, a level that would place it on par with India’s information
technology industry today. India’s biotechnology trade group noted that for nearly a decade the industry had generated a compounded annual growth rate of around 20 percent. It reasoned that if the government took steps to improve the business environment and worked with industry and academia to make a unified
effort to capitalize on the nation’s strengths in biotechnology, the industry in India could accelerate its average growth rate to about 30 percent a year and reach $100 billion by 2025.
June 24, 2014
Serenus Biotherapeutics sees large potential market in Africa
San Francisco's newest pharmaceutical company is staking its future on a distant continent: Africa.
June 18, 2014
Serenus Biotherapeutics looks to tap Africa's underdeveloped market
Sub-Saharan Africa's economic takeoff has carried a growing number of the region's 1.1 billion people ahead on a wave of innovation, bringing new advances in mobile commerce, bioagriculture and green energy. Innovative drugs from the West, however, have arrived much more slowly. (Subscription required).
June 18, 2014
Serenus Biotherapeutics, Inc. Established to Bring Innovative Therapies to Sub-Saharan Africa
San Francisco and Johannesburg—June 18, 2014—Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Sub-Saharan Africa, announced its launch. Menghis Bairu, M.D., the former Executive Vice President, Chief Medical Officer, and Head of Global Development of Elan Corporation will lead the new company.
May 28, 2014
On World MS Day, It's Time to Recognize Our Differences
May 28 marks World MS Day, a time meant to raise awareness about the neurodegenerative disease multiple sclerosis. MS is a complex autoimmune disease that differs from patient to patient. It differs in the way the disease may manifest itself. It differs in the way the disease progresses. And, it differs in the way an individual’s own immune system turns against his or her central nervous system to wreak havoc. No two MS patients are the same, and yet we continue to treat the approximately 2.3 million people worldwide with MS as if they were.
April 1, 2014
Burrill Media releases Biotech 2014-Life Sciences: Transforming Healthcare, its 28th annual report on the life sciences
Burrill’s 28th annual report is an invaluable, one-stop resource for making sense of today’s changing life sciences landscape.
January 8, 2014
Levine Media Group Announces Launch
Strategic communications firm created to the serve distinct needs of life sciences companies.